These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33914240)

  • 1. Double positivity of anti-β
    Yun J; Gu J; Kim HK
    J Thromb Thrombolysis; 2021 Nov; 52(4):1133-1136. PubMed ID: 33914240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
    Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
    Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
    Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
    Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
    Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT
    J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
    Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
    Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.
    Bradáčová P; Slavík L; Skoumalová A; Úlehlová J; Kriegová E; Manukyan G; Friedecký D; Piskláková B; Ullrychová J; Procházková J; Hluší A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.
    Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE.
    Elbagir S; Diaz-Gallo LM; Grosso G; Zickert A; Gunnarsson I; Mahler M; Svenungsson E; Rönnelid J
    Rheumatology (Oxford); 2023 Feb; 62(2):924-933. PubMed ID: 35642868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
    Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
    Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution of antiphosphatidylserine/prothrombin (anti-PS/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)].
    Delarue A; Dragon-Durey MA; Darnige L
    Rev Med Interne; 2022 Sep; 43(9):545-551. PubMed ID: 35752484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the classics: The emerging value of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome.
    Ding Z; Pan H; Yang Z; Yang C; Shi H
    Clin Immunol; 2023 Nov; 256():109804. PubMed ID: 37838215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
    Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
    Front Immunol; 2020; 11():584241. PubMed ID: 33178218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.